Carbo Medicinalis (Activated Charcoal)
Over-the-counter adsorbent used for acute diarrhea and emergency poisoning management
Carbo medicinalis contains activated charcoal, a highly porous form of carbon with an exceptionally large surface area. When taken orally, it adsorbs harmful, unwanted, or disease-causing substances in the gastrointestinal tract, preventing their absorption into the body. It is primarily used as a supportive treatment for acute diarrhea and is a cornerstone of emergency poisoning management worldwide. This over-the-counter medication is available in 250 mg tablets and 150 mg/ml oral suspension, and is generally well tolerated with minimal side effects.
Quick Facts
Key Takeaways
- Carbo medicinalis (activated charcoal) is an OTC adsorbent that binds toxins and harmful substances in the GI tract, preventing absorption into the body.
- It is primarily used for acute diarrhea (as a dietary supplement) and in emergency medicine for poisoning management, though it should not be used for corrosive substance poisoning.
- The recommended adult dose is 3–6 tablets (250 mg each) as needed; if diarrhea persists beyond 3 days, medical consultation is advised.
- Activated charcoal may reduce the effectiveness of other oral medications, including oral contraceptives — take other medicines at least 2 hours apart.
- It is safe during pregnancy and breastfeeding, has minimal side effects (mainly constipation and black stools), and does not enter the bloodstream.
What Is Carbo Medicinalis and What Is It Used For?
Carbo medicinalis is a pharmaceutical preparation of activated charcoal (also known as activated carbon or medicinal charcoal). The active substance undergoes a specialized manufacturing process that creates an extremely porous structure with a vast internal surface area — typically between 950 and 2,000 square meters per gram. This enormous surface area is what gives activated charcoal its remarkable adsorptive capacity, allowing it to bind a wide range of substances through van der Waals forces.
When taken orally, activated charcoal travels through the gastrointestinal tract without being absorbed into the bloodstream. Along the way, it adsorbs harmful, unwanted, or disease-causing substances, effectively preventing them from crossing the intestinal wall and entering systemic circulation. This mechanism of action makes it useful in two main clinical contexts: the management of acute diarrhea and the emergency treatment of certain types of poisoning or drug overdose.
For acute diarrhea, Carbo medicinalis is used as a supportive treatment alongside dietary modifications. It helps by adsorbing toxins produced by bacteria or other irritants in the gut, which can reduce the severity and duration of diarrheal episodes. It is important to note that activated charcoal addresses the symptom rather than the underlying cause, and persistent diarrhea lasting more than three days should prompt medical evaluation.
In the context of poisoning management, activated charcoal has been a mainstay of emergency medicine for decades. The American Academy of Clinical Toxicology (AACT) and the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) recommend single-dose activated charcoal for many types of poisoning when administered within one to two hours of ingestion. In hospital settings, higher doses (typically 50–100 g for adults) are used, and in some cases, multiple-dose activated charcoal (MDAC) may be employed for substances with prolonged absorption phases or enterohepatic circulation.
Activated charcoal is available in multiple formulations to suit different clinical needs and patient populations. The 250 mg tablet form is convenient for self-treatment of mild diarrhea, while the 150 mg/ml oral suspension allows for more precise dosing and is easier to administer to patients who have difficulty swallowing tablets. In emergency departments, activated charcoal is typically available in larger preparations specifically designed for poisoning management.
What Should You Know Before Taking Carbo Medicinalis?
Contraindications
There are several important situations where Carbo medicinalis should not be used. Understanding these contraindications is essential for safe use of this medication. If any of the following conditions apply to you, do not take Carbo medicinalis and consult a healthcare provider:
- Allergy: You are allergic to activated charcoal or any of the other ingredients in this medicine (sucrose, lactose monohydrate, magnesium stearate, or carmellose sodium).
- Bowel obstruction (ileus): You have a confirmed or suspected blockage in the intestines, as the charcoal could worsen the obstruction.
- Acute abdominal pain: Severe or sudden abdominal pain of unknown cause requires medical evaluation before taking any medications.
- Ulcerative colitis: Active inflammatory bowel disease affecting the colon is a contraindication for activated charcoal use.
- Corrosive poisoning: Do not use activated charcoal for poisoning with corrosive substances such as strong acids, alkalis, or petroleum products. These require immediate medical attention and specific treatment protocols.
Warnings and Precautions
When using Carbo medicinalis, there are several important precautions to keep in mind. While this medication is generally very safe, awareness of its effects and limitations helps ensure optimal treatment outcomes.
Black stools: Carbo medicinalis will turn your stools black. This is a completely normal and expected effect of taking activated charcoal and is not a cause for concern. The discoloration occurs because the charcoal passes through the digestive system without being absorbed and is excreted in the feces. This effect will resolve once you stop taking the medication.
Poisoning with corrosive substances: In cases of poisoning with corrosive agents such as strong acids (e.g., hydrochloric acid, sulfuric acid) or strong bases (e.g., sodium hydroxide), Carbo medicinalis should not be used. These substances cause direct chemical burns to the esophagus and stomach lining, and activated charcoal does not effectively adsorb them. Additionally, administering charcoal in this context may obscure the extent of tissue damage during endoscopic examination. If corrosive poisoning is suspected, contact emergency services immediately.
Fluid intake: When taking activated charcoal for diarrhea, it is particularly important to maintain adequate fluid intake. Diarrhea itself causes fluid loss, and activated charcoal may contribute to constipation, which can be worsened by dehydration. Drink plenty of water and consider oral rehydration solutions if diarrhea is severe or prolonged.
Duration of treatment: If diarrhea does not improve after three days of treatment with Carbo medicinalis, discontinue use and consult a doctor. Persistent diarrhea may indicate an underlying condition that requires specific diagnosis and treatment, such as bacterial infection, inflammatory bowel disease, or other gastrointestinal disorders.
Pregnancy and Breastfeeding
Pregnancy: Carbo medicinalis is not expected to pose any risk to the developing fetus at recommended dosages. Activated charcoal is not absorbed from the gastrointestinal tract into the bloodstream, meaning it cannot cross the placenta or reach the fetus. It can be used safely during pregnancy. However, as with any medication during pregnancy, it is advisable to consult your healthcare provider before use, especially if you are taking prenatal vitamins or other medications, as activated charcoal may reduce their absorption.
Breastfeeding: There are no known effects of Carbo medicinalis on the breastfed infant. Since activated charcoal is not absorbed into the bloodstream, it cannot pass into breast milk. It can be used safely during breastfeeding without concerns about effects on the nursing infant.
Driving and Operating Machinery
Carbo medicinalis has no known effect, or a negligible effect, on your ability to drive vehicles or operate machinery. The activated charcoal acts locally in the gastrointestinal tract and is not absorbed systemically, so it does not affect cognitive function, alertness, or motor skills.
Important Information About Excipients
Carbo medicinalis tablets contain sucrose and lactose as inactive ingredients. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medication.
Each tablet contains less than 1 mmol (23 mg) of sodium, which means it is essentially sodium-free and is suitable for patients on a sodium-restricted diet.
How Does Carbo Medicinalis Interact with Other Drugs?
The most clinically significant aspect of activated charcoal's pharmacology is its ability to adsorb other substances in the gastrointestinal tract. This property, while therapeutically valuable for poisoning management, becomes a concern when activated charcoal is taken alongside other oral medications. The charcoal does not distinguish between harmful substances and beneficial medications — it will adsorb both with similar efficiency.
As a general rule, all oral medications should be taken at least 2 hours before or after Carbo medicinalis to minimize the risk of reduced absorption. This timing allows the other medication to be adequately absorbed before the charcoal is introduced, or allows the charcoal to pass through the critical absorption zones of the GI tract before the other medication is taken.
Major Interactions
The following table summarizes the most clinically important drug interactions with activated charcoal. These interactions can significantly reduce the effectiveness of the co-administered medication and may require additional precautions or alternative treatments.
| Medication | Effect of Interaction | Recommendation |
|---|---|---|
| Oral contraceptives (birth control pills) | Significantly reduced absorption; contraceptive failure possible | Use additional contraception (e.g., barrier method) for the remainder of the cycle |
| Antibiotics (e.g., tetracycline, ciprofloxacin) | Reduced antibiotic absorption; treatment failure possible | Take antibiotics at least 2 hours before or after activated charcoal |
| Antiepileptics (e.g., carbamazepine, phenytoin) | Reduced drug levels; risk of breakthrough seizures | Avoid concurrent use; consult physician before using activated charcoal |
| Cardiac glycosides (e.g., digoxin) | Reduced digoxin absorption; potential loss of cardiac rhythm control | Separate administration by at least 2 hours; monitor digoxin levels |
| Theophylline | Enhanced theophylline clearance (used therapeutically in overdose) | Avoid concurrent use for regular therapy; consult physician |
| Paracetamol / Acetaminophen | Reduced absorption and bioavailability | Take at least 2 hours apart for therapeutic use; charcoal is used in overdose treatment |
Minor Interactions
In addition to the major interactions listed above, activated charcoal can potentially reduce the absorption of vitamins and minerals taken as supplements, iron preparations, and antacids. While these interactions are generally less clinically significant, they can affect nutritional status if activated charcoal is used regularly over extended periods. If you are taking any supplements or over-the-counter medications, maintain the recommended 2-hour separation between doses.
The interaction between activated charcoal and oral contraceptives (birth control pills) deserves particular attention. If you take activated charcoal within 2–3 hours of your birth control pill, the contraceptive may not be fully absorbed. In this situation, the World Health Organization (WHO) selected practice recommendations suggest using an additional barrier method of contraception (such as condoms) for the remainder of that menstrual cycle to ensure protection against unintended pregnancy.
What Is the Correct Dosage of Carbo Medicinalis?
Always take Carbo medicinalis exactly as described in the package leaflet or as directed by your doctor, pharmacist, or nurse. If you are unsure, consult a healthcare professional before taking this medication. The dosage varies significantly depending on the indication — self-treatment of diarrhea requires much smaller doses than emergency poisoning management.
Adults
For Acute Diarrhea (Self-Treatment)
The recommended dose is 3–6 tablets (750–1500 mg) taken as needed. Tablets can be taken one to several times daily, before or after meals, swallowed with a full glass of water. For those who have difficulty swallowing tablets, they can first be dissolved in a small amount of water to form a slurry.
Duration: If diarrhea does not resolve within 3 days of treatment, discontinue use and consult a doctor to determine the underlying cause.
For Poisoning (Under Medical Supervision Only)
In emergency poisoning situations, much larger doses are used and should only be administered by or under the direction of healthcare professionals. The standard single dose recommended by the AACT/EAPCCT is 50–100 g (typically as oral suspension), ideally within 1 hour of poison ingestion. For multiple-dose activated charcoal (MDAC), repeated doses of 25–50 g may be given every 2–4 hours as directed by the treating physician.
Children
For self-treatment of diarrhea in children, activated charcoal should generally be used under medical advice. The dose may be adjusted based on the child's age and weight. For poisoning emergencies in children, the standard recommendation is 1 g per kg of body weight (up to a maximum of 50 g), administered as an oral suspension under medical supervision. Younger children may resist taking activated charcoal due to its appearance and gritty texture; in such cases, it may be mixed with a sweet beverage, though this can slightly reduce its adsorptive capacity.
Elderly
No specific dose adjustments are required for elderly patients when using Carbo medicinalis for diarrhea. However, elderly individuals should be particularly vigilant about maintaining adequate fluid intake during episodes of diarrhea, as they are more susceptible to dehydration. If constipation develops as a side effect, medical advice should be sought. Elderly patients taking multiple regular medications should be especially careful to separate the timing of activated charcoal from their other medications by at least 2 hours.
| Patient Group | Indication | Recommended Dose | Notes |
|---|---|---|---|
| Adults | Acute diarrhea | 3–6 tablets (750–1500 mg) PRN | Up to several times daily; max 3 days |
| Adults | Poisoning | 50–100 g single dose | Under medical supervision only |
| Children (>1 year) | Poisoning | 1 g/kg (max 50 g) | Under medical supervision only |
| Elderly | Acute diarrhea | 3–6 tablets PRN | Ensure adequate hydration; monitor for constipation |
Missed Dose
Carbo medicinalis is taken on an as-needed basis rather than on a regular schedule, so the concept of a “missed dose” does not typically apply. If you are using it for diarrhea management, simply take your next dose when symptoms occur. Do not take a double dose to make up for a missed one.
Overdose
If you or someone else has taken an excessively large amount of Carbo medicinalis, or if a child has accidentally ingested the medication, contact a healthcare provider, hospital, or poison control center for assessment and advice. While activated charcoal is generally considered safe even in large doses (given its use in high-dose poisoning treatment), very large amounts may potentially lead to constipation or, in rare cases, intestinal obstruction. The risk of serious adverse effects from overdose is extremely low because activated charcoal is not absorbed into the body.
What Are the Side Effects of Carbo Medicinalis?
Like all medicines, Carbo medicinalis can cause side effects, although not everybody gets them. Activated charcoal has one of the most favorable safety profiles of any medication, owing largely to the fact that it is not absorbed into the bloodstream. The vast majority of people who take activated charcoal at recommended doses for diarrhea experience no adverse effects whatsoever.
It is important to distinguish between true side effects and the expected pharmacological effects of the medication. The most notable expected effect is black discoloration of stools, which occurs in virtually all patients who take activated charcoal. This is a harmless cosmetic effect that resolves once the medication is discontinued.
Common
May affect up to 1 in 10 people
- Constipation
- Black-colored stools (expected effect, not harmful)
Uncommon
May affect up to 1 in 100 people
- Nausea
- Vomiting (especially with large doses)
- Abdominal discomfort or bloating
Rare
May affect up to 1 in 1,000 people
- Intestinal obstruction (with very large doses or pre-existing conditions)
- Aspiration pneumonitis (risk in unconscious patients during poisoning treatment)
- Diarrhea (paradoxical effect with osmotic preparations)
Constipation is the most commonly reported side effect and occurs because activated charcoal adsorbs water and other substances in the intestine, which can slow intestinal transit. This effect is usually mild and self-limiting, but can be managed by increasing fluid intake and dietary fiber. If constipation becomes troublesome, consult your healthcare provider.
Aspiration (inhalation of charcoal into the lungs) is a serious but rare complication that is essentially limited to hospital poisoning treatment scenarios, particularly in patients with a reduced level of consciousness. This is why activated charcoal for poisoning should only be administered by trained healthcare professionals who can protect the patient's airway. In the self-treatment setting for diarrhea, where patients are alert and conscious, the risk of aspiration is negligible.
If you experience any side effects not listed here, or if any side effect becomes severe, contact your doctor, pharmacist, or nurse. Reporting suspected adverse reactions helps regulatory authorities continuously monitor the benefit-risk balance of the medication.
How Should You Store Carbo Medicinalis?
Proper storage of Carbo medicinalis is important to maintain its effectiveness and safety throughout its shelf life. Activated charcoal is a stable compound, but it should be stored correctly to preserve its adsorptive properties.
- Keep in the original container: Store the tablets in the polyethylene jar with lid to protect them from moisture and environmental contaminants, which could reduce the charcoal's adsorptive capacity.
- Keep out of sight and reach of children: Store the medication in a secure location where children cannot access it. While activated charcoal is not toxic, accidental ingestion by children should be avoided.
- Check the expiry date: Do not use Carbo medicinalis after the expiry date (EXP) stated on the label. The expiry date refers to the last day of that month.
- Proper disposal: Do not dispose of unused medications by flushing them down the toilet or throwing them in household waste. Return unused medicines to a pharmacy for safe disposal. These measures help protect the environment.
No special temperature requirements are specified for Carbo medicinalis; normal room temperature storage is sufficient. However, avoid storing the product in excessively hot, cold, or humid environments, as extreme conditions may affect the integrity of the tablet formulation over time.
What Does Carbo Medicinalis Contain?
Active Ingredient
The active substance is activated charcoal (charcoal, activated; carbo activatus). Each tablet contains 250 mg of activated charcoal. This is a specially processed form of carbon with an extremely high surface area and porosity, designed to maximize its capacity to adsorb substances in the gastrointestinal tract. The activated charcoal used in pharmaceutical preparations meets specific pharmacopoeial standards for purity, adsorptive capacity, and particle size.
Inactive Ingredients (Excipients)
The other ingredients in Carbo medicinalis 250 mg tablets are:
- Sucrose: A sugar used as a binder and filler in the tablet formulation.
- Lactose monohydrate: A milk sugar used as a diluent and filler. Patients with lactose intolerance should be aware of this ingredient.
- Magnesium stearate: A lubricant that prevents the tablet material from sticking to manufacturing equipment during production.
- Carmellose sodium: A cellulose derivative used as a disintegrant, helping the tablet break apart when it contacts water in the stomach.
Appearance and Pack Sizes
Carbo medicinalis 250 mg tablets are black, round tablets with a diameter of 13 mm. They are available in polyethylene jars with polyethylene lids in two pack sizes: 75 tablets and 250 tablets. Not all pack sizes may be marketed in all countries.
The oral suspension formulation (150 mg/ml) contains activated charcoal suspended in a liquid vehicle, allowing for easier administration and more flexible dosing. This formulation is particularly useful in emergency medicine settings and for patients who cannot swallow tablets.
Frequently Asked Questions About Carbo Medicinalis
Carbo medicinalis (activated charcoal) is primarily used for two purposes: as a supportive treatment for acute diarrhea and as an emergency treatment for certain types of poisoning. For diarrhea, it works by adsorbing toxins and irritants in the gut that may be causing the symptoms. For poisoning, it is administered in hospital settings in much larger doses to prevent the absorption of ingested toxins. It is available over the counter for diarrhea management and does not require a prescription.
Take 3–6 tablets (250 mg each) as needed, one to several times daily, before or after meals. Swallow the tablets with a full glass of water. If you have difficulty swallowing tablets, you can dissolve them in a small amount of water first. If your diarrhea does not improve within 3 days, stop taking the medication and consult a doctor to investigate the underlying cause.
Carbo medicinalis can reduce the effectiveness of virtually any oral medication when taken at the same time, because activated charcoal adsorbs substances indiscriminately. This is particularly important for oral contraceptives (birth control pills), where reduced absorption could lead to contraceptive failure. Always take other medications at least 2 hours before or after Carbo medicinalis. If you are taking birth control pills and use activated charcoal, consider using an additional barrier method of contraception for the remainder of your cycle.
Yes, Carbo medicinalis is considered safe during both pregnancy and breastfeeding at recommended doses. Activated charcoal is not absorbed into the bloodstream — it acts only locally in the gastrointestinal tract and is excreted unchanged in the feces. This means it cannot cross the placenta to reach the developing fetus, nor can it pass into breast milk. However, pregnant women should be aware that activated charcoal may reduce the absorption of prenatal vitamins if taken at the same time, so maintain at least a 2-hour gap between doses.
Black-colored stools are a completely normal and expected effect of taking activated charcoal. The charcoal passes through your digestive system without being absorbed, and its black color is directly visible in the stool. This is not a sign of internal bleeding or any other medical problem. The discoloration will return to normal once you stop taking the medication. If you have concerns about stool color changes that persist after discontinuing activated charcoal, consult your healthcare provider.
Do not take Carbo medicinalis if you have a bowel obstruction (ileus), suspected intestinal blockage, acute abdominal pain of unknown origin, ulcerative colitis, or an allergy to any of the ingredients. It should also not be used for poisoning with corrosive substances (strong acids or alkalis), as activated charcoal is ineffective against these agents and may interfere with emergency treatment. People with rare hereditary sugar intolerances should also avoid this product due to its sucrose and lactose content.
References
This article is based on international medical guidelines, product information approved by regulatory authorities, and peer-reviewed scientific literature. All medical claims are supported by evidence level 1A where applicable.
- Chyka PA, Seger D, Krenzelok EP, Vale JA. Position paper: Single-dose activated charcoal. Clinical Toxicology. 2005;43(2):61-87. doi:10.1081/CLT-200051867
- Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology (AACT); European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). Clinical Toxicology. 1999;37(6):731-751.
- Juurlink DN. Activated charcoal for acute overdose: a reappraisal. British Journal of Clinical Pharmacology. 2016;81(3):482-487. doi:10.1111/bcp.12793
- World Health Organization (WHO). WHO Model List of Essential Medicines, 23rd list. Geneva: WHO; 2023. Available at: who.int
- European Medicines Agency (EMA). Activated charcoal: Summary of product characteristics. ema.europa.eu
- British National Formulary (BNF). Activated charcoal. National Institute for Health and Care Excellence (NICE). bnf.nice.org.uk
- Olson KR. Activated charcoal for acute poisoning: one toxicologist's journey. Journal of Medical Toxicology. 2010;6(2):190-198. doi:10.1007/s13181-010-0046-1
- Zellner T, Prasa D, Farber E, Hoffmann-Walbeck P, Genser D, Eyer F. The use of activated charcoal to treat intoxications. Deutsches Arzteblatt International. 2019;116(18):311-317. doi:10.3238/arztebl.2019.0311
- Silberman J, Galuska MA, Taylor A. Activated Charcoal. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. NCBI Bookshelf
Editorial Team
This article was written and reviewed by the iMedic Medical Editorial Team, comprising specialists in pharmacology, toxicology, and clinical medicine. All content follows international guidelines and is regularly updated to reflect current evidence.
Medical Content Team
Clinical Pharmacology & Toxicology Specialists
Board-certified physicians with expertise in pharmacology, drug safety, and poison management. Content follows WHO, EMA, and FDA guidelines.
Medical Review Board
Independent Quality Assurance
All content independently reviewed using the GRADE evidence framework. No commercial funding or pharmaceutical industry involvement.